首页> 外文期刊>Cost Effectiveness Resource Allocation >Cost analyses of obesity in Canada: scope, quality, and implications
【24h】

Cost analyses of obesity in Canada: scope, quality, and implications

机译:加拿大肥胖症的成本分析:范围,质量和意义

获取原文
           

摘要

Background Rapid changes in lifestyle have led to a global obesity epidemic. Understanding the economic burden associated with the obesity epidemic is essential to decision making of cost-effective interventions. This study reviewed costs of obesity and intervention programs in Canada, assessed the scope and quality of existing cost analyses, and identified implications for economic evaluations and public health decision makers. Methods A systematic search of costs associated with obesity or intervention program in Canada between 1990 and 2011 yielded 10 English language articles eligible for review. Results The majority of studies was prevalence-based or top-down costing; 40% had excellent quality assessed using the Quality of Health Economic Study scale. The aggregated annual costs of obesity in Canada ranged from 1.27 to 11.08 billion dollars. Direct costs accounted for 37.2% to 54.5% of total annual costs. Between 2.2% and 12.0% of Canada's total health expenditures were attributable to obesity. The average annual physician cost of overweight male ($ 427) and female ($ 578) adults was lower than that of obese male ($ 475) and female ($ 682) adults; this cost differential across weight status groups was comparable to that found in adolescents. The cost for implementation and maintenance of a school-based obesity prevention program was $ 23 per student. Conclusions We observed high costs associated with overweight and obesity and modest costs for obesity prevention programs; however, no cost-effectiveness study of obesity interventions has been performed in Canada. Cost-effectiveness analyses of preventive programs that constitute incidence-based life-time modeling of costs and health outcomes from societal perspective are urgently needed.
机译:背景技术生活方式的快速变化已导致全球性肥胖病流行。了解与肥胖流行有关的经济负担,对于制定具有成本效益的干预措施至关重要。这项研究回顾了加拿大肥胖症和干预计划的成本,评估了现有成本分析的范围和质量,并确定了对经济评估和公共卫生决策者的影响。方法对1990年至2011年间加拿大与肥胖症或干预计划相关的费用进行系统搜索,得出10篇符合审查条件的英语文章。结果多数研究是基于流行率或自上而下的成本计算的。 40%的人使用卫生质量经济研究量表评估了优异的质量。在加拿大,每年肥胖症的总花费在1.27美元至110.8亿美元之间。直接费用占年度总费用的37.2%至54.5%。加拿大的总卫生支出中有2.2%至12.0%可归因于肥胖。超重男性(427美元)和女性(578美元)成年人的年均医生费用低于肥胖男性(475美元)和女性(682美元)的成年人;体重状况各组之间的成本差异与青少年的差异相当。实施和维护基于学校的肥胖预防计划的成本为每位学生23美元。结论我们观察到与超重和肥胖相关的高成本以及肥胖预防计划的适度成本。但是,加拿大尚未进行肥胖干预的成本效益研究。迫切需要对预防计划进行成本效益分析,从社会角度分析这些构成成本和健康结果的基于发病率的终生模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号